Foundation Medicine, Inc.·4

May 23, 4:06 PM ET

Miller Vincent A. 4

4 · Foundation Medicine, Inc. · Filed May 23, 2018

Insider Transaction Report

Form 4
Period: 2018-05-21
Miller Vincent A.
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2018-05-21$85.00/sh1,570$133,45070,088 total
  • Exercise/Conversion

    Common Stock

    2018-05-21$29.94/sh+1,570$47,00671,658 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-05-211,5700 total
    Exercise: $29.94Exp: 2024-04-09Common Stock (1,570 underlying)
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
  • [F2]This stock option was granted on April 9, 2014 and vested in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION